TW200501963A - Pharmaceutical compositions comprising epinastine for the treatment of skin diseases - Google Patents
Pharmaceutical compositions comprising epinastine for the treatment of skin diseasesInfo
- Publication number
- TW200501963A TW200501963A TW093109279A TW93109279A TW200501963A TW 200501963 A TW200501963 A TW 200501963A TW 093109279 A TW093109279 A TW 093109279A TW 93109279 A TW93109279 A TW 93109279A TW 200501963 A TW200501963 A TW 200501963A
- Authority
- TW
- Taiwan
- Prior art keywords
- epinastine
- treatment
- pharmaceutical compositions
- group
- skin diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03007778 | 2003-04-04 | ||
EP03007759 | 2003-04-04 | ||
EP03007779 | 2003-04-04 | ||
EP03008989A EP1468696A1 (en) | 2003-04-17 | 2003-04-17 | Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200501963A true TW200501963A (en) | 2005-01-16 |
Family
ID=33136052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093109279A TW200501963A (en) | 2003-04-04 | 2004-04-02 | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040247686A1 (zh) |
JP (1) | JP2006522053A (zh) |
AR (1) | AR044209A1 (zh) |
PE (1) | PE20040961A1 (zh) |
TW (1) | TW200501963A (zh) |
WO (1) | WO2004087167A2 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030104017A1 (en) * | 2001-10-26 | 2003-06-05 | Boehringer Ingelheim International Gmbh | Epinastine formulation for oral administration |
DE102005001645A1 (de) * | 2005-01-13 | 2006-07-20 | Gerhard Dr. Sauermann | Topisches Produkt zur Vorbeugung und Behandlung von Windeldermatitis |
WO2007007851A1 (en) * | 2005-07-08 | 2007-01-18 | Senju Pharmaceutical Co., Ltd. | Percutaneously absorptive ophthalmic preparation comprising epinastine |
IL172896A0 (en) * | 2005-12-29 | 2006-06-11 | Yeda Res & Dev | Cxcr4 inhibition |
WO2007110380A1 (en) * | 2006-03-25 | 2007-10-04 | Boehringer Ingelheim International Gmbh | Insect bite relief preparation comprising epinastine |
JP4300370B2 (ja) * | 2007-03-13 | 2009-07-22 | 春三 小林 | 上皮改善剤 |
EP2164481A2 (de) * | 2007-06-08 | 2010-03-24 | Bayer Consumer Care AG | Arzeimittel mit einer wirkstoffkombination enthaltend pantothensäure oder deren derivate zur behandlung von allergischen symptomen |
FR2918876B1 (fr) * | 2007-07-16 | 2012-10-05 | Oreal | Utilisation de lumiere verte pour activer la l-amino acide oxydase |
DE102008006394A1 (de) * | 2008-01-28 | 2009-07-30 | Beiersdorf Ag | Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien |
WO2010082177A2 (en) * | 2009-01-16 | 2010-07-22 | Sederma | New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
US20140220136A1 (en) * | 2013-02-05 | 2014-08-07 | Bordoloi Biotech, Llc | System and method for delivering protease inhibitors |
CN106659733A (zh) * | 2014-07-01 | 2017-05-10 | E·查康 | 治疗创伤用局部组合物和方法 |
PL238310B1 (pl) * | 2017-10-31 | 2021-08-09 | Top Energy Set Spolka Z Ograniczona Odpowiedzialnoscia | Preparat leczniczy oraz sposób jego uzyskiwania |
AU2021410145A1 (en) * | 2020-12-24 | 2023-07-27 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition for topical administration containing epinastine or salt thereof |
JP7171971B1 (ja) * | 2020-12-24 | 2022-11-15 | 参天製薬株式会社 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
CN112915084B (zh) * | 2021-04-13 | 2022-08-02 | 陕西医药控股医药研究院有限公司 | 一种治疗老年性皮肤瘙痒症的药物组合物及外用制剂 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8517299D0 (en) * | 1985-07-09 | 1985-08-14 | Salim A S M | Dermatologically active substances |
US20020103137A1 (en) * | 1997-03-30 | 2002-08-01 | Shiseido Co., Ltd. | Method of treating environmental stress |
JPH11158025A (ja) * | 1997-09-26 | 1999-06-15 | Shiseido Co Ltd | 皮膚外用剤 |
JPH11100320A (ja) * | 1997-09-29 | 1999-04-13 | Risuburan:Kk | 皮膚外用剤 |
JP4016128B2 (ja) * | 1999-09-09 | 2007-12-05 | 東和薬品株式会社 | 耐光性塩酸エピナスチンフィルムコート錠 |
JP2001097888A (ja) * | 1999-09-28 | 2001-04-10 | Hiroshi Ikeno | 外用組成物 |
DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
WO2003002125A2 (en) * | 2001-06-29 | 2003-01-09 | Astion A/S | Combination of aminosugars and cysteine or cysteine derivatives |
JP2003026608A (ja) * | 2001-07-10 | 2003-01-29 | Nof Corp | 皮膚外用剤組成物 |
DE10152973A1 (de) * | 2001-10-26 | 2003-05-08 | Boehringer Ingelheim Int | Neue trockene und wässrige Epinastin-Sirup-Formulierung |
US20030104017A1 (en) * | 2001-10-26 | 2003-06-05 | Boehringer Ingelheim International Gmbh | Epinastine formulation for oral administration |
-
2004
- 2004-03-18 US US10/803,674 patent/US20040247686A1/en not_active Abandoned
- 2004-04-01 JP JP2006504940A patent/JP2006522053A/ja active Pending
- 2004-04-01 WO PCT/EP2004/003440 patent/WO2004087167A2/en active Application Filing
- 2004-04-02 AR ARP040101121A patent/AR044209A1/es unknown
- 2004-04-02 TW TW093109279A patent/TW200501963A/zh unknown
- 2004-04-02 PE PE2004000352A patent/PE20040961A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20040961A1 (es) | 2005-01-05 |
US20040247686A1 (en) | 2004-12-09 |
JP2006522053A (ja) | 2006-09-28 |
WO2004087167A3 (en) | 2004-11-25 |
AR044209A1 (es) | 2005-09-07 |
WO2004087167A2 (en) | 2004-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200501963A (en) | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases | |
WO2003105800A3 (de) | Filmförmige mucoadhäsive darreichungsformen zur verabreichung von cannabis-wirkstoffen | |
MY140576A (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms | |
EA200600190A1 (ru) | Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона | |
HK1076605A1 (en) | Formulations | |
CA2498047A1 (en) | Novel imidazole compounds as transforming growth factor (tgf) inhibitors | |
TW200504069A (en) | Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors | |
TW200517388A (en) | Thiazole derivatives as cannabinoid receptor modulators | |
WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
WO2005037798A3 (en) | Amide or thiomide derivatives and their use in the treatment of pain | |
MXPA06000660A (es) | Uso de una composicion cosmetica o farmaceutica que comprende un extracto rico en lupeol, como un ingrediente activo para estimular la sintesis de proteinas de choque termico. | |
WO2004058721A3 (en) | Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity | |
GB0623258D0 (en) | Thiadiazole derivatives for the treatment of neuro-degenerative diseases | |
UA92498C2 (ru) | Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм | |
HK1098352A1 (en) | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis | |
MXPA05010614A (es) | Uso de derivados de 10-hidroxi-10,11-dihidrocarbamazepina para el tratamiento de trastornos afectivos. | |
TW200740440A (en) | Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient | |
MXPA02006511A (es) | Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido. | |
UA83870C2 (ru) | Замещенные бицикло[3.1.1]гептаном производные бензимидазолона и хиназолинона как агонисты человеческих рецепторов orl1 | |
MX2023001572A (es) | Formas farmaceuticas sólidas de palbociclib. | |
MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
YU24603A (sh) | Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin | |
WO2005035500A3 (en) | Therapeutic agents useful for treating pain | |
ECSP055804A (es) | Composición farmacéutica |